Report of Foreign Issuer (6-k)
April 15 2019 - 4:31PM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of the
Securities Exchange Act of 1934
April 15, 2019
Commission File Number: 001-36686
Forward Pharma A/S
Østergade 24A, 1st Floor
1100 Copenhagen K, Denmark
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):
☐
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):
☐
Item 1. Notice to Convene Annual General Meeting
On April 15, 2019, Forward Pharma A/S (the “Company”)
mailed to its shareholders a notice to convene the 2019 annual general meeting of shareholders on May 8, 2019 and accompanying
documentation. The notice and accompanying documentation have been posted on the Company’s website, http://forward-pharma.com,
and are being furnished as exhibits to this Report on Form 6-K.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
FORWARD PHARMA A/S
|
|
|
|
|
|
|
Date: April 15, 2019
|
By:
|
/s/ Claus Bo Svendsen
|
|
|
|
Name: Claus Bo Svendsen
|
|
|
Title: Chief Executive Officer
|
EXHIBIT INDEX
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jul 2023 to Jul 2024